All stock reports

GUFICBIO evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-09T23:42:15.834577+00:00

Metrics

latest_annual_period
2026-03-31
revenue
9440066000.0
net_income
642147000.0
operating_cash_flow
131705000.0
free_cash_flow
-180107000.0
total_assets
13423740000.0
total_liabilities
6773873000.0
total_equity
6649486000.0
cash
762170000.0
total_debt
4047533000.0
revenue_growth
0.15150012948186875
earnings_growth
-0.07803071091680491
net_margin
0.06802357102164328
roe
0.09657092292547123
debt_to_equity
0.6086986272322402
cash_conversion
0.2051010126964698
free_cash_flow_margin
-0.019078997964632874
trailing_pe
34.75
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

No qualifying opportunity

No candidate at another positional horizon in the coherent source run.

  • No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
Decision ID
decision-217437af0fce6cec893e7d31163bb0f52eb90cb10a68a62898eb7fb53423bef3
Policy
stock-decisions-v1
Evidence bundle hash
9e9a56488f3d0391bacee4411d8a0f0292c2467ba43870421e405464faef2baf
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: ed01721111dac955a8f928e1746f561c5ba4ac10a704767b4b27accf61b6af30
  • daily-price: 016b7bed40550cebcb3569f9d8731d1f0f6c6f7f40d585d7f3849150360e91c9
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The cached closing price on 2026-10-01 was INR 418.40. The trailing 5-session price return was -0.85%. The trailing 20-session price return was -4.65%. The trailing 60-session price return was 10.12%. The trailing 250-session price return was 15.75%.

Risks

The closing price was -5.96% below its highest close in the available trailing year. Financial data check: weak_cash_conversion: operating cash flow/net income below 0.5. The cached financial metric free cash flow margin is -0.019078997964632874. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

Average cached traded value over twenty sessions was INR 35,176,078. The cached financial metric latest annual period is 2026-03-31. The cached financial metric revenue growth is 0.15150012948186875. The cached financial metric net margin is 0.06802357102164328. The cached financial metric roe is 0.09657092292547123. The cached financial metric debt to equity is 0.6086986272322402.

Cached observations and evidence limits